Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligoprogression”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Not applicableLooking for participantsNCT06101277
What this trial is testing

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Who this might be right for
Esophageal CancerSmall Bowel CancerGastroesophageal-junction Cancer+8 more
University of California, Davis 300
Testing effectiveness (Phase 2)Looking for participantsNCT06870942
What this trial is testing

Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy

Who this might be right for
HCC - Hepatocellular CarcinomaRadiotherapy
Shanghai Zhongshan Hospital 35
Large-scale testing (Phase 3)Looking for participantsNCT06523673
What this trial is testing

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung CancerNSCLC Stage IVOligoProgressive Metastatic Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University 104
Testing effectiveness (Phase 2)UnknownNCT05387044
What this trial is testing

SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors

Who this might be right for
NSCLC Stage IV
Zhejiang Cancer Hospital 28
Large-scale testing (Phase 3)Looking for participantsNCT06585007
What this trial is testing

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerOligoprogressive
Universitaire Ziekenhuizen KU Leuven 246
Not applicableLooking for participantsNCT06918951
What this trial is testing

Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers

Who this might be right for
OligoprogressionOligometastatic DiseaseOligoProgressive Metastatic Disease
British Columbia Cancer Agency 194
Not applicableLooking for participantsNCT07121335
What this trial is testing

SMC Radiation Oncology SABR Cohort for Oligometastasis

Who this might be right for
Stereotactic Body Radiation Therapy (SBRT)OligometastasisOligoprogression+2 more
Samsung Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT04892953
What this trial is testing

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Who this might be right for
Stage III Lung Cancer AJCC v8Stage III Lung Non-Small Cell Cancer AJCC v7Stage IIIA Lung Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT06927635
What this trial is testing

Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

Who this might be right for
Castrate Resistance Prostate CancerOligoProgressive Metastatic Disease
University Health Network, Toronto 75
Testing effectiveness (Phase 2)Study completedNCT02759835
What this trial is testing

Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib

Who this might be right for
Lung AdenocarcinomaLung Neoplasms
National Cancer Institute (NCI) 37
Large-scale testing (Phase 3)Looking for participantsNCT06841172
What this trial is testing

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

Who this might be right for
OligoProgressive Metastatic DiseaseHepatocellular Carcinoma (HCC)Radiotherapy+1 more
Shandong Cancer Hospital and Institute 132
Testing effectiveness (Phase 2)Ended earlyNCT05846659
What this trial is testing

Study of PULSAR-ICI +/- IMSA101 in Patients with Oligoprogressive Solid Tumor Malignancies

Who this might be right for
Oligoprogressive
ImmuneSensor Therapeutics Inc. 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07333651
What this trial is testing

125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer

Who this might be right for
Oligometastatic Disease
Li Min 90
Large-scale testing (Phase 3)Active Not RecruitingNCT07076693
What this trial is testing

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

Who this might be right for
OligoProgressive Metastatic DiseaseNon-Small Cell Lung Cancer
Shanghai Chest Hospital 97
Testing effectiveness (Phase 2)Looking for participantsNCT04405401
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

Who this might be right for
Lung Cancer Metastatic
Centre hospitalier de l'Université de Montréal (CHUM) 68
Not applicableLooking for participantsNCT06103682
What this trial is testing

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

Who this might be right for
Non-small Cell Lung CancerOligoprogressiveSmall-cell Lung Cancer
University of California, Davis 100
Testing effectiveness (Phase 2)WithdrawnNCT06331585
What this trial is testing

Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy

Who this might be right for
Low-dose RadiotherapyTumor MicroenvironmentNon-Small Cell Lung Cancer
Hetian District People's Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT05990192
What this trial is testing

SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy

Who this might be right for
Ovarian Cancer Recurrent
Institute of Cancer Research, United Kingdom 42
Large-scale testing (Phase 3)UnknownNCT03256981
What this trial is testing

Stereotactic Body Radiotherapy for the Treatment of OPD

Who this might be right for
NSCLC
Institute of Cancer Research, United Kingdom 113
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06813664
What this trial is testing

CtDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)

Who this might be right for
Metastatic NSCLC - Non-Small Cell Lung CancerOligoProgressive Metastatic Disease
University Health Network, Toronto 60
Load More Results